Transfer factor (IMUNOR) administration in women with chronic vulvovaginal discomfort: clinical study result
2012
Abstract
A study on the effect of administration of the transfer-factor (IMUNOR) on the changes in subjective complaints in women suffering from chronic vulvovaginal discomfort of unclear etiology. The patients themselves assessed their subjective complaints based on their intensity using a 0-10 scale rating system. 28 women at fertile age were included in the study.
After the loading dose was administered, IMUNOR 10 mg was taken on an empty stomach once a week for a perion of 3 months.